Researchers from the Centre for Genomic Regulation (CRG) in Barcelona reprogramme lymphoma and leukaemia cells to halt their malignancy. Resulting cells remain benign even when no longer subjected to treatment and reduce ...
Apr 3, 2013
0
0
An interdisciplinary team of researchers from the University of Vienna (Institute of Inorganic Chemistry) and the Medical University of Vienna (Institute for Cancer Research) has successfully developed a new strategy for ...
Sep 26, 2014
0
0
Researchers have devised a new test to help doctors diagnose ovarian tumours and choose the most appropriate treatment.
Oct 16, 2014
0
0
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection ...
Feb 19, 2014
0
0
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center (CCC) of MedUni Vienna and Vienna General Hospital have now managed ...
Dec 13, 2018
0
0
Since January 2014, the HELICOID project has been developing hyperspectral imaging technologies capable of differentiating between healthy and diseased tissues. The February 2015 meeting in Brussels enabled project partners ...
Mar 6, 2015
0
7
Researchers from the Institute of Neuroscience (INc) of the Universitat Autonoma de Barcelona (UAB) have identified the biochemical and molecular alteration that causes resistance to radiotherapy and chemotherapy in the glioblastoma ...
Feb 19, 2016
0
0
Despite the fact that the cure rate for breast cancer, the most common cancer in women, is very high (around 80%), this disease can nevertheless have very serious consequences. The majority of breast cancer-related deaths ...
Nov 12, 2013
0
0
Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, ...
Aug 8, 2012
0
0
The monoclonal antibodies nivolumab and ipilimumab have already undergone several early benefit assessments in various oncological indications. Since April 2021, the drug combination has also been approved for first-line ...
Oct 4, 2021
0
0
